[go: up one dir, main page]

HN2008000621A - Metodo para la anticopcepcion hormonal preventiva bajo demanda - Google Patents

Metodo para la anticopcepcion hormonal preventiva bajo demanda

Info

Publication number
HN2008000621A
HN2008000621A HN2008000621A HN2008000621A HN2008000621A HN 2008000621 A HN2008000621 A HN 2008000621A HN 2008000621 A HN2008000621 A HN 2008000621A HN 2008000621 A HN2008000621 A HN 2008000621A HN 2008000621 A HN2008000621 A HN 2008000621A
Authority
HN
Honduras
Prior art keywords
anticopception
hormonal
preventive
under demand
present
Prior art date
Application number
HN2008000621A
Other languages
English (en)
Inventor
Schmidt-Gollwitzer Karim
Stock Gunter
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of HN2008000621A publication Critical patent/HN2008000621A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA PRESENTE INVENCION SE RELACION A CON UN METODO DE ANTICOPCEPCION HORMONAL QUE COMPRENDE ADMINISTRAR UNA PREPARACION FARMACEUTCA QUE COMPRENDE AL MENOS UN PROGESTOGENO POR VIA TRANSDERMICA, BAJO DEMANDA Y EN UNA SOLA OCASION, EN ANTICIPACION DEL ENCUENTRO SEXUAL. NOTA: LA PRESENTE INVENCION REIVINDICA LOS COMPUESTOS DE PROGESTOGENOS SELECCIONADOS DE LOS SIGUIENTES: DESOGESTREL, ETONORGESTREL, GESTODENO, LEVONORGESTREL, TRIMEGESTONA. TAMBIEN REIVINDICA UN ESTROGENO COMO EL ETINILESTRADIOL
HN2008000621A 2005-10-19 2008-04-21 Metodo para la anticopcepcion hormonal preventiva bajo demanda HN2008000621A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005050729A DE102005050729A1 (de) 2005-10-19 2005-10-19 Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption

Publications (1)

Publication Number Publication Date
HN2008000621A true HN2008000621A (es) 2011-07-22

Family

ID=37762565

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2008000621A HN2008000621A (es) 2005-10-19 2008-04-21 Metodo para la anticopcepcion hormonal preventiva bajo demanda

Country Status (13)

Country Link
US (3) US20070111976A1 (es)
EP (1) EP1937275A1 (es)
JP (2) JP2009512658A (es)
KR (1) KR20080056774A (es)
CN (1) CN101340915A (es)
BR (1) BRPI0617683A2 (es)
CA (1) CA2626567C (es)
CR (1) CR9908A (es)
DE (1) DE102005050729A1 (es)
EC (1) ECSP088390A (es)
GT (1) GT200800038A (es)
HN (1) HN2008000621A (es)
WO (1) WO2007045513A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2710293A1 (en) * 2007-12-20 2009-07-02 Teva Women's Health, Inc. Dosage regimens and pharmaceutical compositions and packages for emergency contraception
DK2419108T3 (en) * 2009-04-14 2016-12-05 Hra Pharma Lab A method for on-demand control of conception,
US20120129825A1 (en) * 2009-04-14 2012-05-24 Andre Ulmann Method for on-demand contraception using levonorgestrel or norgestrel
DE102010040299A1 (de) 2010-09-06 2012-03-08 Bayer Schering Pharma Aktiengesellschaft Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner)
EP3936133A1 (en) 2011-11-23 2022-01-12 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
HK1207588A1 (en) 2012-11-22 2016-02-05 Bayer Pharma Aktiengesellschaft Use and application regimen of a pharmaceutical composition containing levonorgestrel and a cox inhibitor for on-demand contraception
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
WO2014187744A1 (de) 2013-05-23 2014-11-27 Bayer Pharma Aktiengesellschaft Pharmazeutische zusammensetzung und deren verwendung sowie anwendungsregime dieser pharmazeutischen zusammensetzung zur bedarfsweisen („on-demand") kontrazeption
US10206932B2 (en) 2014-05-22 2019-02-19 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
CA3020153A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5512292A (en) * 1990-10-29 1996-04-30 Alza Corporation Transdermal contraceptive formulations methods and devices
DE4229820C2 (de) * 1992-09-07 1998-12-03 Jenapharm Gmbh Pharmazeutische Zubereitung auf Gestagen-Basis
DE4405898A1 (de) * 1994-02-18 1995-08-24 Schering Ag Transdermale therapeutische Systeme enthaltend Sexualsteroide
CA2203541A1 (en) * 1994-10-24 1996-05-02 Kristof Chwalisz Competitive progesterone antagonists for demand-oriented female birth control
IL148415A0 (en) * 1999-08-31 2002-09-12 Jenapharm Gmbh Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives
US7384650B2 (en) * 1999-11-24 2008-06-10 Agile Therapeutics, Inc. Skin permeation enhancement composition for transdermal hormone delivery system
WO2003093322A2 (en) * 2002-04-30 2003-11-13 The Population Council, Inc. Carrageenan based antimicrobial compositions
UA89766C2 (en) * 2003-12-12 2010-03-10 Байер Шеринг Фарма Акциенгезельшафт Transdermal delivery system of gestodene
MXPA06006682A (es) * 2003-12-12 2006-08-11 Schering Ag Hormonas de administracion transdermica que no necesitan potenciadores de penetracion.

Also Published As

Publication number Publication date
DE102005050729A1 (de) 2007-04-26
US20130089574A1 (en) 2013-04-11
JP2009512658A (ja) 2009-03-26
CR9908A (es) 2008-05-21
BRPI0617683A2 (pt) 2011-08-02
EP1937275A1 (de) 2008-07-02
WO2007045513A1 (de) 2007-04-26
GT200800038A (es) 2009-04-01
CN101340915A (zh) 2009-01-07
US20080311180A1 (en) 2008-12-18
CA2626567C (en) 2013-12-03
US20070111976A1 (en) 2007-05-17
JP2014001239A (ja) 2014-01-09
KR20080056774A (ko) 2008-06-23
CA2626567A1 (en) 2007-04-26
ECSP088390A (es) 2008-05-30

Similar Documents

Publication Publication Date Title
HN2008000621A (es) Metodo para la anticopcepcion hormonal preventiva bajo demanda
PE20211588A1 (es) Compuestos y sus usos para aliviar sintomas asociados a la menopausia
CL2011003172A1 (es) Composicion farmaceutica que comprende a) un excepiente, b) al menos un precursor de esteroides sexuales, c) al menos un modulador selectivo del receptor de estrogenos o una antiestrogeno y no contiene una progestina y/o un estrogeno; kit farmaceutico; y uso para reducir o eliminar sofocos, sintomas vasomotores y sudores nocturnos.
PE20120860A1 (es) Combinacion farmaceutica que comprende levonorgestrel en combinacion con piroxicam, indometacina o diclofenaco
CR7611A (es) Uso de derivados de cilotiocarbamato en tratamiento de condiciones relacionadas con la hormona
PE20060275A1 (es) Composicion farmaceutica que contiene progestina y estrogeno para el tratamiento de trastorno disforico premenstrual
AR082998A1 (es) Asociacion farmaceutica para tratar y/o prevenir mioma y/o endometriosis, uso de resveratrol y progestogeno, composicion farmaceutica para tratamiento y/o prevencion de mioma y/o endometriosis, medicamento para tratamiento y/o prevencion de mioma y/o endometriosis, kit y metodo para tratamiento y/o prevencion de mioma y/o endometriosis
AR057060A1 (es) Composiciones de tanaproget que contienen etinil estradiol
ECSP088123A (es) Anticoncepcion oral con trimegestona
AR032204A1 (es) Complejos de inclusion de ciclodextrina-drospirenona
ECSP088796A (es) Metodos para la prevencion y tratamiento de condiciones que surgen de deficiencia de estrogeno local
PA8805001A1 (es) Sistema de administracion vaginal
PE20070327A1 (es) Composicion que comprende una progestina y un estrogeno
ECSP056095A (es) Métodos y composiciones farmacéuticas para la obtención confiable de niveles aceptables de testosterona en suero
NI201000183A (es) Regímenes de dosificación de antiprogestina.
UY33343A (es) Formas de dosificación sólidas orales con dosis muy bajas para la hrt
IN2012DN04867A (es)
PE20040157A1 (es) Progestinas no esteroides
DOP2012000325A (es) Derivados de 6,7-dihidro-5h-benzo (7)anulenos, metodos para su preparacion, preparaciones farmaceuticas que los contienen y su uso para la preparacion de medicamentos
PE20061415A1 (es) Composicion farmaceutica que contiene gestagenos y/o estrogenos y 5-metil-(6s)-tetrahidrofolato
ECSP055574A (es) Uso de derivados de tio-oxindol en el tratamiento de condiciones relacionadas con hormonas.
GT200900296A (es) Composición farmacéutica que comprende la combinación de un agente anti inflamatorio no esteroideo y un agente anticonvulsivante.
AR043013A1 (es) Composicion farmaceutica destinada al tratamiento de la endometriosis
UY32005A (es) Derivados de estratrieno que comprenden bioisósteros heterocíclicos para el anillo fenólico a
DOP2010000017A (es) Estratrienos 8-beta-sustituidos como estrogenos de accion selectiva